BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8664181)

  • 1. Angioimmunoblastic T-cell lymphoma: new insights, but the clinical challenge remains.
    Jaffe ES
    Ann Oncol; 1995 Sep; 6(7):631-2. PubMed ID: 8664181
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary cerebral angioimmunoblastic T-cell lymphoma.
    Lachenal F; Berger F; Cimarelli S; Formaglio M; Ghesquières H
    J Clin Oncol; 2013 Feb; 31(5):e64-8. PubMed ID: 23295811
    [No Abstract]   [Full Text] [Related]  

  • 3. Single-agent lenalidomide is effective in the treatment of a heavily pretreated and refractory angioimmunoblastic T-cell lymphoma patient.
    Broccoli A; Pellegrini C; Celli M; Argnani L; Agostinelli C; Pileri S; Zinzani PL
    Clin Lymphoma Myeloma Leuk; 2014 Aug; 14(4):e119-22. PubMed ID: 24629851
    [No Abstract]   [Full Text] [Related]  

  • 4. CD20 expression in angioimmunoblastic T cell lymphoma.
    Foukas PG; Kefala M; Papageorgiou S; Tsirigotis P; Panayiotidis P; Korkolopoulou P; Spathis A; Dervenoulas J; Patsouris E; Karakitsos P; Panayiotides IG
    Leuk Lymphoma; 2012 Feb; 53(2):345-7. PubMed ID: 21919822
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of darinaparsin for EBV-associated B-cell lymphoma in a heavily treated elderly patient with angioimmunoblastic T-cell lymphoma: a case report.
    Ikeda D; Oura M; Uehara A; Tabata R; Narita K; Takeuchi M; Matsue K
    Leuk Lymphoma; 2024 Jan; 65(1):132-135. PubMed ID: 37794793
    [No Abstract]   [Full Text] [Related]  

  • 6. Pralatrexate and angioimmunoblastic T-cell lymphoma: time for a second look?
    van der Weyden C; Harrop S; Prince HM
    Leuk Lymphoma; 2020 Sep; 61(9):2031-2033. PubMed ID: 32729765
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma with fludarabine.
    Tsatalas C; Margaritis D; Kaloutsi V; Martinis G; Kotsianidis I; Bourikas G
    Acta Haematol; 2001; 105(2):106-8. PubMed ID: 11408715
    [No Abstract]   [Full Text] [Related]  

  • 8. Unusual relapse of an angioimmunoblastic T cell lymphoma 11 years after initial manifestation.
    Lohneis P; Jakob C; Hummel M; Jöhrens K; Anagnostopoulos I
    Ann Hematol; 2015 Feb; 94(2):347-9. PubMed ID: 24923452
    [No Abstract]   [Full Text] [Related]  

  • 9. Angioimmunoblastic T-cell lymphoma mimicking Crohn's disease.
    Kang HY; Hwang JH; Park YS; Bang SM; Lee JS; Chung JH; Kim H
    Dig Dis Sci; 2007 Oct; 52(10):2743-7. PubMed ID: 17394065
    [No Abstract]   [Full Text] [Related]  

  • 10. Uncommon late relapse of angioimmunoblastic T-cell lymphoma after 16-year remission period.
    Páyer E; Miltényi Z; Simon Z; Szabados L; Hegyi K; Méhes G; Illés A
    Pathol Oncol Res; 2012 Jul; 18(3):737-41. PubMed ID: 22127590
    [No Abstract]   [Full Text] [Related]  

  • 11. Targeting CD52 as a novel therapeutic strategy in angioimmunoblastic T-cell lymphoma.
    Dunleavy K; Wilson WH
    Leuk Lymphoma; 2010 Sep; 51(9):1583-4. PubMed ID: 20795788
    [No Abstract]   [Full Text] [Related]  

  • 12. c-Maf expression in angioimmunoblastic T-cell lymphoma reflects follicular helper T-cell derivation rather than oncogenesis.
    Bisig B; Thielen C; Herens C; Gofflot S; Travert M; Delfau-Larue MH; Boniver J; Gaulard P; de Leval L
    Histopathology; 2012 Jan; 60(2):371-6. PubMed ID: 22126447
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapy refractory angioimmunoblastic T-cell lymphoma in complete remission with lenalidomide.
    Beckers MM; Huls G
    Eur J Haematol; 2013 Feb; 90(2):162-3. PubMed ID: 23227803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis and treatment of angioimmunoblastic T-cell lymphoma].
    Tobinai K
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():525-30. PubMed ID: 23134010
    [No Abstract]   [Full Text] [Related]  

  • 15. Fever, rash, and eosinophilia - early signs of angioimmunoblastic T-cell lymphoma.
    Wawrzycki B; Prystupa A; Szumiło J; Panasiuk L; Krasowska D
    Ann Agric Environ Med; 2021 Sep; 28(3):525-530. PubMed ID: 34558280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Angioimmunoblastic lymphadenopathy. Apropos a case with unusual clinical manifestations and evolution to T-cell lymphoma].
    de la Torre Lima FJ; Rubio Rubio JM; Garrachón Vallo F; Pichardo Carballo JJ; Sánchez López MP; Zamora Madaria E
    An Med Interna; 1994 Sep; 11(9):442-4. PubMed ID: 7858088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel tumour-infiltrating lymphocyte-related risk stratification based by flow cytometry for patients with de novo angioimmunoblastic T cell lymphoma.
    Zhu Q; Deng X; Yao W; Chen Z; Ye Y; Gao L; Zhang W; Liu W; Zhao S
    Ann Hematol; 2021 Mar; 100(3):715-723. PubMed ID: 33389024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angioimmunoblastic T-Cell Lymphoma with Polyarthritis Resembling Rheumatoid Arthritis.
    Yachoui R; Farooq N; Amos JV; Shaw GR
    Clin Med Res; 2016 Dec; 14(3-4):159-162. PubMed ID: 28188140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunoblastic lymphadenopathy-like T cell lymphoma with high level of serum interleukin-2 and various allergic reactions].
    Tsujisaki M; Nakahara S; Kazama Y; Shimizu H; Yoshimoto M; Takahashi T; Okada Y; Sasaki S; Imai K
    Nihon Rinsho Meneki Gakkai Kaishi; 2002 Dec; 25(6):452-7. PubMed ID: 12630426
    [No Abstract]   [Full Text] [Related]  

  • 20. Guillain Barré syndrome heralding the diagnosis of angioimmunoblastic T-cell lymphoma.
    Pathak P; Perimbeti S; Ames A; Moskowitz AJ
    Leuk Lymphoma; 2019 Jul; 60(7):1835-1838. PubMed ID: 30648445
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.